Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study. (Q48678943)

14 February 2018

title

Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study. (English)

1 reference

14 February 2018

positron emission tomography

0 references

1 reference

1 reference

1 reference

Tatsuhiro Terada

1

1 reference

14 February 2018

Masamichi Yokokura

2

1 reference

14 February 2018

Etsuji Yoshikawa

3

1 reference

14 February 2018

Masami Futatsubashi

4

1 reference

14 February 2018

Satoshi Kono

5

1 reference

14 February 2018

Takashi Konishi

6

1 reference

14 February 2018

Hiroaki Miyajima

7

1 reference

14 February 2018

Takanori Hashizume

8

1 reference

14 February 2018

Yasuomi Ouchi

9

1 reference

14 February 2018

publication date

14 June 2016

1 reference

14 February 2018

Annals of Nuclear Medicine

published in

1 reference

14 February 2018

volume

30

1 reference

14 February 2018

page(s)

579-587

1 reference

14 February 2018

issue

8

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/s12149-016-1099-2

exact match

0 references

cites work

Microglial activation and dopamine terminal loss in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Neuroinflammation in the living brain of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Common inflammatory mechanisms in Lewy body disease and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

The 39-Item Parkinson's Disease Questionnaire (PDQ-39): Is it a Unidimensional Construct?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

The Mini-Mental State Examination: A Comprehensive Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C]DPA713 versus [11C]( R)PK11195.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Neuroprotective effects of zonisamide target astrocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Zonisamide has beneficial effects on Parkinson's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1099-2

10.1007/S12149-016-1099-2

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

27299437

1 reference

14 February 2018